US45784P1012
© BusinessWire
15.12.2025
PODD
LISTED
NASDAQ
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod brand of products, has announced the expansion of its U.S. Pod recycling program, which is now available to all U.S. customers.
“Here at Insulet, our mission is to transform the lives of people with diabetes, and...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
PODD
LISTED
NASDAQ
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark in...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2025
PODD
LISTED
NASDAQ
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today hosted its 2025 Investor Day at the Company’s global headquarters in Acton, Massachusetts.
During the event, Insulet’s executive team outlined the strategic plan and innovation roadmap...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
06.11.2025
PODD
LISTED
NASDAQ
Insulet Reports Third Quarter 2025 Results
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three months ended September 30, 2025.
Third Quarter Financial Highlights:
Revenue of $706.3 million, increased 29.9%, or 28.2% in constant currency...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
30.10.2025
PODD
LISTED
NASDAQ
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its new campaign, “The Day Diabetes Showed Up to Work,” in honor of Diabetes Awareness Month, which starts November 1.
“Nearly 590 million people worldwide live with diabetes1, an...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
PODD
LISTED
NASDAQ
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Robert (“Robbie”) L. Huffines, a former Global Chair of Investment Banking at JP Morgan Chase & Co., to the Company’s board of directors, effective October 31...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
PODD
LISTED
NASDAQ
Insulet to Host Investor Day on November 20, 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company’s Acton, Massachusetts headquarters on Thursday, November 20, 2025.
The Investor Day will include presentations from the management team highlighting the...
Themefolio
Profiler
Peergroup
© BusinessWire
18.09.2025
PODD
LISTED
NASDAQ
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Pantone®, the global authority on color and provider of professional color standards for the design industries, today announced the creation of Omnipod Mango, a bright and joyful tropical orang...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
PODD
LISTED
NASDAQ
Insulet Announces CFO Transition
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succeed Ana Maria Chadwick as Executive Vice President, Chief Financial Officer, effective September 30, 2025. Ms. Chadwick will become a Senior Advisor t...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
PODD
LISTED
NASDAQ
Insulet Elevates Eric Benjamin to Chief Operating Officer
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Eric Benjamin to Chief Operating Officer effective immediately. The Company also announced the appointment of Manoj Raghunandanan as Chief Growth Officer.
This p...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
PODD
LISTED
NASDAQ
Insulet to Participate in Upcoming Investor Conferences
News Preview
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the upcoming investor conferences (all Eastern Time):
Wells Fargo 2025 Healthcare Conference in Boston on September 4 at 3:00 p.m.
Baird 2025 Global Healthcare Conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
08.07.2025
PODD
LISTED
NASDAQ
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the second quarter of 2025 on August 7, 2025, before the opening of the financial markets. In connection with the release, management will host...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
19.06.2025
PODD
LISTED
NASDAQ
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its planned activities during the American Diabetes Association (ADA) 85th Scientific Sessions taking place June 20 – 23, 2025 at the McCormick Place Convention Center in Chicago, I...
Themefolio
Profiler
Peergroup
© BusinessWire
10.06.2025
PODD
LISTED
NASDAQ
Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
News Preview
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System.
With this latest integration, the Omnipod 5 Automated Insulin Delivery (AID) System combines the benefits of tubeless...
Themefolio
Profiler
Peergroup
© BusinessWire
23.05.2025
PODD
LISTED
NASDAQ
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 in Miami on Tuesday, June 10, 2025 at 9:20 a.m. (Eastern Time).
To listen to the live audio webcast...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
PODD
LISTED
NASDAQ
Insulet Announces Publication of 2024 Sustainability Report
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, is proud to announce the publication of its 2024 Sustainability Report. This report underscores Insulet's unwavering commitment to sustainable practices and highlights significant achievements in e...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
PODD
LISTED
NASDAQ
Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended March 31, 2025.
“Our first quarter results showcase the strong execution and dedication of the Insulet team, who has continued to expan...
Themefolio
Profiler
Peergroup
© BusinessWire
28.04.2025
PODD
LISTED
NASDAQ
Insulet Appoints Ashley McEvoy President and CEO
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its Board of Directors has appointed Ashley McEvoy President and Chief Executive Officer and a member of the Board of Directors, effective immediately.
Ms. McEvoy succeeds Jim...
Themefolio
Profiler
Peergroup
© PR Newswire
07.04.2025
PODD
LISTED
NASDAQ
Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above
News Preview
New Diabetes Canada Guidelines1 recommend people with type 1 diabetes use an Automated Insulin Delivery System (AID) System for diabetes managementApproximately 300,000 Canadians have type 1 diabetes, with the number of cases growing at an estimated 4.4% per year2The Omnipod 5 System is designed to be customer-centric and aims to deliver exceptio...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
PODD
LISTED
NASDAQ
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2025 on May 8, 2025, after the close of the financial markets. In connection with the release, management will host a...
Themefolio
Profiler
Peergroup
© BusinessWire
19.03.2025
PODD
LISTED
NASDAQ
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today shared new Omnipod 5 clinical data from its RADIANT study. Results from this multinational randomized controlled trial were presented at the 18th International Conference on Advanced Technolo...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
PODD
LISTED
NASDAQ
Insulet Announces Pricing of Senior Notes Due 2033
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has priced a private placement of $450 million aggregate principal amount of senior unsecured notes due 2033 (the “Notes”). The Notes will bear interest at an annual rate of 6.50% and will matu...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
PODD
LISTED
NASDAQ
Insulet Announces Proposed Financing Transactions
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its intention to offer, subject to market and other conditions, $450 million aggregate principal amount of senior unsecured notes due 2033 (the “Notes”) in a private placement....
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
PODD
LISTED
NASDAQ
Insulet Expands Omnipod® 5 to Four More International Markets
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its revolutionary Omnipod 5 Automated Insulin Delivery (AID) System is now available in Australia and will soon be offered in three additional countries, helping transform the lives...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
PODD
LISTED
NASDAQ
From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Company will present results from its multinational Randomized Controlled Trial to Demonstrate the Efficacy of Omnipod 5 Compared with Multiple Daily Injections for Treatment of...
Themefolio
Profiler
Peergroup
© BusinessWire
11.03.2025
PODD
LISTED
NASDAQ
Insulet to Host Investor Day on June 5, 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company's global headquarters in Acton, Massachusetts on Thursday, June 5, 2025.
Presentations will be led by Jim Hollingshead, President and CEO, members of the E...
Themefolio
Profiler
Peergroup
© BusinessWire
20.02.2025
PODD
LISTED
NASDAQ
Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months and full year ended December 31, 2024.
"We concluded an incredible year with a very strong fourth quarter, achieving significant milestones a...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
PODD
LISTED
NASDAQ
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now commercially available in five more countries—Italy, Denmark, Finland, Norway, and Sweden.
Omnipod 5 is now available with b...
Themefolio
Profiler
Peergroup
© BusinessWire
10.01.2025
PODD
LISTED
NASDAQ
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the fourth quarter and full year of 2024 on February 20, 2025, after the close of the financial markets. In connection with the release, m...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2024
PODD
LISTED
NASDAQ
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that it has successfully defended its intellectual property against EOFlow Co., Ltd. (“EOFlow") in federal court.
After a four-week trial in the U.S. District Court for the District of...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2024
PODD
LISTED
NASDAQ
Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S. This makes Omnipo...
Themefolio
Profiler
Peergroup
© BusinessWire
15.11.2024
PODD
LISTED
NASDAQ
Insulet to Present at Upcoming Investor Conferences
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming investor conferences (all Eastern Time):
The 6th Annual Wolfe Research Healthcare Conference in New York City on Wednesday, November 20, 2024 at 1...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
PODD
LISTED
NASDAQ
Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended September 30, 2024.
“We continue to achieve significant milestones and robust revenue growth," said Jim Hollingshead, President and Chi...
Themefolio
Profiler
Peergroup
© BusinessWire
01.11.2024
PODD
LISTED
NASDAQ
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to recognize National Diabetes Awareness Month and World Diabetes Day with a series of activities in November.
“People with diabetes must make dozens of decisions every day t...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2024
PODD
LISTED
NASDAQ
Omnipod® 5 App for iPhone® Now Fully Available in the United States
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the full market release of the Omnipod 5 App for iPhone® in the U.S.
Now available to download for free on the Apple App Store, the App allows users to fully control their Omnipod...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2024
PODD
LISTED
NASDAQ
National Campaign Launches to Combat Diabetes Stigma Using Comedy
News Preview
SAN FRANCISCO, Oct. 10, 2024 /PRNewswire/ -- The Spoonful of Laughter campaign is a national initiative using comedy to educate about diabetes, counter harmful stereotypes and stigma, and amplify authentic, respectful, and empowering representations of people living with diabetes.
The Spoonful of Laughter campaign is...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2024
PODD
LISTED
NASDAQ
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the third quarter of 2024 on November 7, 2024 after the close of the financial markets. In connection with the release, management will ho...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2024
PODD
LISTED
NASDAQ
Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its groundbreaking Omnipod 5 Automated Insulin Delivery System (Omnipod 5) is now indicated for use by people with type 2 diabetes (ages 18 years and older) in the U.S., making it t...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2024
PODD
LISTED
NASDAQ
Insulet to Present at Upcoming Investor Conferences
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming investor conferences (all Eastern Time):
The 2024 Wells Fargo Healthcare Conference in Boston on Wednesday, September 4, 2024 at 9:30 a.m.
The...
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2024
PODD
LISTED
NASDAQ
Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today hosted a grand opening celebration at its new manufacturing facility in Johor Bahru, Malaysia.
This press release features multimedia. View the full release here: https://www.businesswire.co...
Themefolio
Profiler
Peergroup
© BusinessWire
08.08.2024
PODD
LISTED
NASDAQ
Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended June 30, 2024.
Second Quarter Financial Highlights:
Second quarter 2024 revenue of $488.5 million, up 23.2%, or 23.4% in constant c...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
